Acura Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
06-14 | Acura Pharmaceuticals, Inc. announced that it has received $0.2 million in funding | CI |
06-04 | Acura Pharmaceuticals, Inc. and Acura Pharmaceutical Technologies, Inc Announce Executive Changes | CI |
Sales 2020 | 3.57M 4.89M | Sales 2021 | 1.56M 2.14M | Capitalization | 32.54M 44.53M |
---|---|---|---|---|---|
Net income 2020 | -1M -1.37M | Net income 2021 | - 0 | EV / Sales 2020 | 2.91 x |
Net Debt 2020 | 5.86M 8.01M | Net Debt 2021 | 135K 185K | EV / Sales 2021 | 20.9 x |
P/E ratio 2020 |
-5.25
x | P/E ratio 2021 |
-25
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 15.72% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 08-04-06 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 98-01-31 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 98-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 98-01-31 |
Bruce Wesson
BRD | Director/Board Member | 81 | 98-02-28 |
William Skelly
BRD | Director/Board Member | 73 | 96-04-30 |
1st Jan change | Capi. | |
---|---|---|
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |